Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Midtvedt

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Clinical Transplantation|February 13, 2009
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantationAnders Asberg, Karsten Midtvedt, Monica H Voytovich, et al.
Diabetologia|December 30, 2015
Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantationJørn P Lindahl, Anders Hartmann, Svend Aakhus, et al.
Transplantation|May 11, 2016
Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific AntibodiesClara García-Carro, Christina Dörje, Anders Åsberg, et al.
Clinical Transplantation|January 31, 2018
Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantationClara García-Carro, Christina Dörje, Anders Åsberg, et al.
Transplantation Direct|March 31, 2021
Blood Pressure Treatment in Kidney Transplant Recipients-Can We Improve?Mari O Onsøien, Karsten Midtvedt, Anna V Reisæter, et al.
Transplantation|February 14, 2014
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipientsIda Robertsen, Anders Asberg, Tone Granseth, et al.
Clinical and Translational Science|July 12, 2020
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant RecipientsMarte Theie Gustavsen, Karsten Midtvedt, Ida Robertsen, et al.
Transplantation|September 11, 2009
Experience from an active preemptive kidney transplantation program--809 cases revisitedBartlomiej J Witczak, Torbjørn Leivestad, Pål Dag Line, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 17, 2019
Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trialMarte Theie Gustavsen, Karsten Midtvedt, Kjersti Lønning, et al.
Blood|November 5, 2005
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infectionEspen Ø Kvale, Jakob Dalgaard, Fridtjof Lund-Johansen, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Clinical Transplantation|February 13, 2009
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantationAnders Asberg, Karsten Midtvedt, Monica H Voytovich, et al.
Diabetologia|December 30, 2015
Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantationJørn P Lindahl, Anders Hartmann, Svend Aakhus, et al.
Transplantation|May 11, 2016
Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific AntibodiesClara García-Carro, Christina Dörje, Anders Åsberg, et al.
Clinical Transplantation|January 31, 2018
Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantationClara García-Carro, Christina Dörje, Anders Åsberg, et al.
Transplantation Direct|March 31, 2021
Blood Pressure Treatment in Kidney Transplant Recipients-Can We Improve?Mari O Onsøien, Karsten Midtvedt, Anna V Reisæter, et al.
Transplantation|February 14, 2014
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipientsIda Robertsen, Anders Asberg, Tone Granseth, et al.
Clinical and Translational Science|July 12, 2020
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant RecipientsMarte Theie Gustavsen, Karsten Midtvedt, Ida Robertsen, et al.
Transplantation|September 11, 2009
Experience from an active preemptive kidney transplantation program--809 cases revisitedBartlomiej J Witczak, Torbjørn Leivestad, Pål Dag Line, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 17, 2019
Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trialMarte Theie Gustavsen, Karsten Midtvedt, Kjersti Lønning, et al.
Blood|November 5, 2005
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infectionEspen Ø Kvale, Jakob Dalgaard, Fridtjof Lund-Johansen, et al.
Pageof 16